Skip to main content

Published locations for VIDEO: Pioglitazone benefited NASH patients with and without T2DM

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. VIDEO: Pioglitazone benefited NASH patients with and without T2DM

User login

  • Reset your password
  • /content/video-pioglitazone-benefited-nash-patients-and-without-t2dm
  • /familypracticenews/article/159443/diabetes/video-pioglitazone-benefited-nash-patients-and-without
  • /gihepnews/article/159443/diabetes/video-pioglitazone-benefited-nash-patients-and-without-t2dm
  • /internalmedicinenews/article/159443/diabetes/video-pioglitazone-benefited-nash-patients-and-without
  • /clinicalendocrinologynews/article/159443/diabetes/video-pioglitazone-benefited-nash-patients-and
  • /endocrinology/article/159443/diabetes/video-pioglitazone-benefited-nash-patients-and-without-t2dm
  • /internalmedicine/article/159443/diabetes/video-pioglitazone-benefited-nash-patients-and-without-t2dm
  • /familymedicine/article/159443/diabetes/video-pioglitazone-benefited-nash-patients-and-without-t2dm
  • /type-2-diabetes-icymi/article/159443/diabetes/video-pioglitazone-benefited-nash-patients-and-without